Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice

Cancer Letters

Volumn 287, Issue 2, 2010, Pages 187-195

  Wu, Jiann Ming ^a   Chen, Yun ^a,b   Chen, Jin Cherng ^c   Lin, Tzu Yu ^a,b   Tseng, Sheng Hong ^b,d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Colon cancer; Mitogen activated protein kinase; Tetrandrine

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TETRANDRINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; GROWTH INHIBITION; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUBCUTANEOUS TISSUE TUMOR; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BENZYLISOQUINOLINES; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR BURDEN;

ANIMALIA; MUS;

EID: 72949109102     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.06.009     Document Type: Article

References (41)

1. Allegra C.J., Palik S., Colangelo L.H., Parr A.L., Kirsch I., Kim G., Klein P., Johnston P.G., Wolmark N., and Wieand H.S. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a national cancer institute-national surgical adjuvant breast and bowel project collaborative study. J. Clin. Oncol. 21 (2003) 241-250
2. Midgley R., and Kerr D. Colorectal cancer. Lancet 353 (1999) 391-399
3. Ho L.J., Chang D.M., Chang M.L., Kuo S.Y., and Lai J.H. Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells. J. Rheumatol. 26 (1999) 14-22
4. Jang B.C., Lim K.J., Paik J.H., Cho J.W., Baek .K., Suh M.H., Park J.B., Kwon T.K., Park J.W., Kim S.P., Shin D.H., Song D.K., Bae J.H., Mun K.C., and Suh S.I. Tetrandrine-induced apoptosis is mediated by activation of caspases and PKC-δ in U937 cells. Biochem. Pharmacol. 67 (2004) 1819-1829
5. Chen Y., Chen J.C., and Tseng S.H. Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. Int. J. Cancer 124 (2009) 2260-2269
6. Lin T.Y., Tseng S.H., Lin S.J., Chen J.C., Shieh J.S., and Chen Y. Tetrandrine increased the survival rate of mice with lipopolysaccharide-induced endotoxemia. J. Trauma 66 (2009) 411-417
7. Wang G., Lemos J.R., and Iadecola C. Herbal alkaloid tetrandrine: from an ion channel blocker to inhibitor of tumor proliferation. Trends Pharmacol. Sci. 25 (2004) 120-123
8. Li S.Y., Ling L.H., Teh B.S., Seow W.K., and Thong Y.H. Anti-inflammatory and immunosuppressive properties of the bisbenzylisoquinolines: in vitro comparison of tetrandrine and berbamine. Int. J. Immunopharmacol. 11 (1989) 359-401
9. Li S.Y., Teh B.S., Seow W.K., Ling L.H., and Thong Y.H. Effect of tetrandrine on immunological response and cardiac transplant rejection in mice. Int. Arch. Allergy Appl. Immunol. 90 (1989) 169-173
10. Koh S.B., Ban J.Y., Lee B.Y., and Seong Y.H. Protective effects of fangchinoline and tetrandrine on hydrogen peroxide-induced oxidative neuronal cell damage in cultured rat cerebellar granule cells. Planta Med. 69 (2003) 506-512
11. Shen Y.C., Chen C.F., and Sung Y.J. Tetrandrine ameliorates ischaemia-reperfusion injury of rat myocardium through inhibition of neutrophil priming and activation. Br. J. Pharmacol. 128 (1999) 1593-1601
12. Jin Q., Kang C., Soh Y., Sohn N.W., Lee J., Cho Y.H., Baik H.H., and Kang I. Tetrandrine cytotoxicity and its dual effect on oxidative stress-induced apoptosis through modulating cellular redox states in Neuro 2a mouse neuroblastoma cells. Life Sci. 71 (2002) 2053-2066
13. Kuo P.L., and Lin C.C. Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells. Life Sci. 73 (2003) 243-252
14. English J., Pearson G., Wilsbacher J., Swantek J., Karandikar M., Xu S., and Cobb M.H. New insights into the control of MAP kinase pathways. Exp. Cell Res. 253 (1999) 255-270
15. Tseng S.H., Wang C.H., Lin S.M., Chen C.K., Huang H.Y., and Chen Y. Activation of c-Jun N-terminal kinase 1 and caspase 3 in the tamoxifen-induced apoptosis of rat glioma cells. J. Cancer Res. Clin. Oncol. 130 (2004) 285-304
16. Park D.S., Stefanis L., Yan C.Y.I., Farinelli S.E., and Greene L.A. Ordering the cell death pathway: differential effects of Bcl2, and interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells. J. Biol. Chem. 271 (1996) 21898-21905
17. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
18. Corbett T.H., Griswold Jr. D.P., Roberts B.J., Peckham J.C., and Schabel Jr. F.M. Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy, assays, with a note on carcinogen structure. Cancer Res. 35 (1975) 2434-2439
19. Chen T.C., Lai Y.K., Yu C.K., and Juang J.L. Enterovirus 71 triggering of neuronal apoptosis through activation of Abl-Cdk5 signalling. Cell. Microbiol. 9 (2007) 2676-2688
20. Liu B., Zou C., and Li Y. Studies of the contents of glycosaminoglycans from lungs of silicotic rats and tetrandrine-treated silicotic rats. Ecotoxicol. Environ. Safety 75 (1998) 47-51
21. Wong C.W., Seow W.K., and Thong Y.H. Comparative effects of tetrandrine and berbamine on acute and relapsing experimental allergic encephalitis in Lewis rats. Int. Arch. Allergy Appl. Immunol. 97 (1992) 31-36
22. Tai K.F., Chen P.J., Chen D.S., and Hwang L.H. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors. J. Gene Med. 5 (2003) 386-398
23. Swiatecka J., Dzieciol J., Anchim T., Dabrowska M., Pietruczuk M., and Wolczynski S. Influence of estrogen, antiestrogen and UV-light on the balance between proliferation and apoptosis in MCF-7 breast adenocarcinoma cell culture. Neoplasma 47 (2000) 15-24
24. Song Q., Baxter G.D., Kovacs E.M., Findik D., and Lavin M.F. Inhibition of apoptosis in human tumour cells by okadaic acid. J. Cell Physiol. 153 (1992) 550-556
25. Cip1. Cancer Res. 64 (2004) 9086-9092
26. Ballif B.A., and Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinas (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ. 12 (2001) 397-408
27. Sebolt-Leopold J.S., Doudley D.T., Herrera R., van Becelaere K., Wiland A., Gowan R.C., Tecle H., Barrett S.D., Bridges A., Przybranowski S., Leopold W.R., and Saltiel A.R. Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat. Med. 5 (1999) 810-816
28. Hayakawa J., Ohmichi M., Kurachi H., Ikegami H., Kimura A., Matsuoka T., Jikihara H., Mercola D., and Murata Y. Inhibition of extracellular signal-regulated protein kinase or c-Jun N-terminal protein kinase cascade, differentially activated by cisplatin, sensitizes human ovarian cancer cell line. J. Biol. Chem. 274 (1999) 31648-31654
29. Persons D.L., Yazlovitskaya E.M., Cui W., and Pelling J.C. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 5 (1995) 1007-1014
30. Schweyer S., Soruri A., Meschter O., Heintze A., Zschunke F., Miosge N., Thelen P., Schlott T., Radzun H.J., and Fayyazi A. Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Br. J. Cancer 91 (2004) 589-598
31. Wang X., Martindale J.L., and Holbrook N.J. Requirement for ERK activation in cisplatin-induced apoptosis. J. Biol. Chem. 275 (2000) 39435-39443
32. Woessmann W., Chen X., and Borkhardt A. Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines. Cancer Chemother. Pharmacol. 50 (2002) 397-404
33. Dolado I., Swat A., Ajenjo N., Cuadrado A., and Nebreda A.R. p38α MAP kinases as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11 (2007) 191-205
34. Sumbayev V.V., and Yasinka I.M. Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species. Arch. Biochem. Biophys. 435 (2005) 406-412
35. Thoms H.C., Dunlop M.G., and Stark L.A. p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of relA and apoptosis in colorectal cancer cells. Cancer Res. 67 (2007) 1660-1669
36. Bulavin D.V., Phillips C., Nannenga B., Timefeev O., Donehower L.A., Anderson C.W., Appella E., and Fornace Jr. A.J. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36 (2004) 343-350
37. Kennedy N.J., Cellurale C., and Davis R.J. A radical role for p38 MAPK in tumor initiation. Cancer Cell 11 (2007) 101-103
38. Lavoie J.N., L'Allemain G., Brunet A., Muller R., and Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271 (1996) 20608-20616
39. Manke I.A., Nguyen A., Lim D., Stewart M.Q., Elia A.E., and Yaffe M.B. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 17 (2005) 37-48
40. Fu L.W., Zhang Y.M., Liang Y.J., Yang X.P., and Pan Q.C. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur. J. Cancer 38 (2002) 418-426
41. Chang K.H., Liao H.F., Chang H.H., Chen Y.Y., Yu M.C., and Chen Y.J. Inhibitory effect of tetrandrine on pulmonary metastases in CT26 colorectal adenocarcinoma-bearing BALB/c mice. Am. J. Chin. Med. 32 (2004) 863-872